Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $3.2150 per EA under NDC 68001049104. Its NADAC has been published 238 times since Aug 4, 2021.
The High Outlier badge above means this manufacturer's average price in the imatinib mesylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001049104
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA078340On Market Since
3/26/2021
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 238 times since Aug 4, 2021, and over the history we have for it it has declined 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2150 per EA |
|---|---|
| All-time high | $3.8646 (Dec 15, 2021) |
| All-time low | $1.4080 (Aug 23, 2023) |
| 52-week high | $3.2150 |
| 52-week low | $2.6631 |
| Median price | $2.5599 |
| Average price | $2.5378 |
| Largest weekly change | +34.7% (May 18, 2022) |
| Weeks tracked | 238 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by BluePoint Laboratories, is $3.2150 per EA (NDC 68001049104), effective Feb 18, 2026.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has declined 5.0%. It has been tracked across 238 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since Aug 4, 2021, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $1.4080 (Aug 23, 2023) to a high of $3.8646 (Dec 15, 2021), with a median of $2.5599 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IMATINIB MESYLATE 400 MG TAB, is $2.0356 per EA — about 37% below IMATINIB MESYLATE 400 MG TAB.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 68001049104) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification